Get the Stockscreener App
10.93
1.97%
-0.22
After Hours:
10.93
Tyra Biosciences Inc stock is traded at $10.93, with a volume of 205.44K.
It is down -1.97% in the last 24 hours and up +14.21% over the past month.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
See More
Previous Close:
$11.15
Open:
$11.01
24h Volume:
205.44K
Relative Volume:
0.64
Market Cap:
$580.27M
Revenue:
-
Net Income/Loss:
$-83.74M
P/E Ratio:
-6.7888
EPS:
-1.61
Net Cash Flow:
$-64.98M
1W Performance:
+1.39%
1M Performance:
+14.21%
6M Performance:
-24.41%
1Y Performance:
-50.68%
1-Day Range:
$10.71
$11.14
1-Week Range:
$10.44
$11.66
52-Week Range:
$6.42
$29.60
Tyra Biosciences Inc Stock (TYRA) Company Profile
Name
Tyra Biosciences Inc
Sector
Industry
Phone
(619) 728-4760
Address
2656 STATE STREET, CARLSBAD
Compare TYRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
10.93 | 592.93M | 0 | -83.74M | -64.98M | -1.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-21-25 | Resumed | Piper Sandler | Overweight |
| Jan-07-25 | Initiated | UBS | Buy |
| Oct-18-24 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-15-24 | Initiated | Piper Sandler | Overweight |
| Dec-15-23 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-30-23 | Initiated | Wedbush | Outperform |
| Feb-03-23 | Initiated | Oppenheimer | Outperform |
| Jun-23-22 | Initiated | H.C. Wainwright | Buy |
| Mar-08-22 | Upgrade | Jefferies | Hold → Buy |
| Nov-08-21 | Downgrade | Jefferies | Buy → Hold |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Oct-11-21 | Initiated | Cowen | Outperform |
| Oct-11-21 | Initiated | Jefferies | Buy |
View All
Tyra Biosciences Inc Stock (TYRA) Latest News
Intrahepatic Cholangiocarcinoma Pipeline Insight 2025: 20+ - openPR.com
Intrahepatic Cholangiocarcinoma Pipeline Insight 2025: 20+ Emerging Therapies Target FGFR2, IDH1/2, and Beyond | DelveInsight - The Globe and Mail
How to integrate Tyra Biosciences Inc. into portfolio analysis toolsHigh Conviction Stock Long-Term Summary - Newser
Relative strength of Tyra Biosciences Inc. in sector analysisEarly Entry Ideas with Momentum Potential - Newser
Can Tyra Biosciences Inc. recover in the next quarterStock Trading Session Highlights and Summary - Newser
What risks could impact Tyra Biosciences Inc. stock performanceReal Market Tracker with Price Action Tools - Newser
What indicators show strength in Tyra Biosciences Inc.Free Price Action Based Buy Opportunity List - Newser
Will Tyra Biosciences Inc. stock benefit from AI tech trendsExpert-Backed High Yield Stock Watchlist - Newser
How to recover losses in Tyra Biosciences Inc. stockDownside Risk Evaluation and Stock Analysis - Newser
Is this a good reentry point in Tyra Biosciences Inc.Real-Time Entry Forecast with Accuracy Metrics - Newser
Non-Muscle Invasive Bladder Cancer Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | Prokarium Ltd., Vaxiion Therapeutics, Tyra Biosciences, Lipac - Barchart.com
How Resilient Is Tyra Biosciences Inc. Stock During Economic DownturnsShort Term Profit Strategy with Entry Cues - Newser
What moving averages say about Tyra Biosciences Inc.Fast Entry Strategy with Price Prediction - Newser
Advanced analytics toolkit walkthrough for Tyra Biosciences Inc.Free Low Drawdown Real Time Trading Tips - Newser
What makes Tyra Biosciences Inc. stock price move sharplyTechnical Trade Plan with Entry Checklist - Newser
What machine learning models say about Tyra Biosciences Inc.Strategy Chart for Real-Time Trade Flow - Newser
What makes Tyra Biosciences Inc. stock attractive to long term investorsHigh Return Stock Focus With Safety Emphasized - metal.it
Why Tyra Biosciences Inc. stock attracts strong analyst attentionFree Breakout Momentum Picks With Protection - Newser
How Tyra Biosciences Inc. stock performs during market volatilityLong Hold Investment Strategy with Growth Focus - Newser
Tyra Biosciences Inc. Recovery Likely Here’s What Data ShowsTop Performing Stock Insights Released Daily - metal.it
Tyra Biosciences Inc. stock chart pattern explainedDaily Market Momentum Summary and Strategy - Newser
When is Tyra Biosciences Inc. stock expected to show significant growthWealth Building Trend Scanner For Smart Trading - jammulinksnews.com
What are analysts’ price targets for Tyra Biosciences Inc. in the next 12 monthsStock Strategy Insights For Fast Growth - jammulinksnews.com
How does Tyra Biosciences Inc. generate profit in a changing economyAchieve consistent high returns with low risk - jammulinksnews.com
What institutional flow reveals about Tyra Biosciences Inc.Long-Term Signal Tracking and Profit Summary - Newser
Is this a good reentry point in Tyra Biosciences Inc. Deep Stock Performance and Volatility Analysis - Newser
How Tyra Biosciences Inc. stock performs during market volatility Market Forecast Summary Over Multi-Year Period - Newser
How does Tyra Biosciences Inc. compare to its industry peersUnlock powerful stock screening techniques - jammulinksnews.com
Does Tyra Biosciences Inc. stock perform well during market downturnsCapitalize on market trends with expert guidance - jammulinksnews.com
How strong is Tyra Biosciences Inc. company’s balance sheetFree Consultation - jammulinksnews.com
What are the latest earnings results for Tyra Biosciences Inc.Robust financial gains - jammulinksnews.com
Is Tyra Biosciences Inc. a growth stock or a value stockCapitalize on emerging market sectors - jammulinksnews.com
Sectors Driving Future Growth for Tyra Biosciences Inc. StockSafer Investing With Bigger Upside - metal.it
Tyra Biosciences Inc Stock (TYRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.43%
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):